Mylan Settles EpiPen Medicaid Overcharge Claims for $465 Million

Mylan agreed to pay $465 million to settle federal government claims that it overcharged the Medicaid program by millions of dollars for its EpiPen products.

from WSJ.com: US Business http://ift.tt/2we8Ti9
via IFTTT